Acadia Healthcare price target lowered to $77 from $80 at Mizuho

Mizuho analyst Ann Hynes lowered the firm’s price target on Acadia Healthcare to $77 from $80 and keeps a Neutral rating on the shares post the Q3 report. The company’s revenue growth was strong, driven by pricing and volume, the analyst tells investors in a research note. The firm reduced estimates and the price target primarily reflect increased interest expense estimates and leverage driven by the recent $400M legal settlement.